Page 19 - Vitro Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In Vitro Diagnostics Market Assessment, By Product Type [Instruments, Reagents and Consumables, Data Management Software], By Techniques...

Surmodics, Inc. (NASDAQ:SRDX – Free Report) – Analysts at Zacks Research increased their FY2023 EPS estimates for Surmodics in a note issued to investors on Wednesday, August 16th. Zacks Research analyst D. Dey now anticipates that the company will post earnings per share of ($0.22) for the year, up from their prior estimate of ($1.90). […]

Shares of Surmodics, Inc. (NASDAQ:SRDX – Get Free Report) reached a new 52-week high during trading on Friday . The company traded as high as $39.22 and last traded at $39.04, with a volume of 18174 shares trading hands. The stock had previously closed at $37.82. Wall Street Analyst Weigh In A number of equities […]

Surmodics (NASDAQ:SRDX – Get Free Report) issued an update on its FY 2023 earnings guidance on Saturday morning. The company provided EPS guidance of -$0.29–$0.14 for the period, compared to the consensus EPS estimate of -$1.30. The company issued revenue guidance of $103.00 million-$106.00 million, compared to the consensus revenue estimate of $116.95 million. Surmodics […]

Surmodics Reports Third Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance August 2, 2023 07:00 a.m. ET ...